Closed systems in cell therapy production are designed to reduce direct exposure of cells and materials to the surrounding environment during manufacturing. These systems can support controlled workflows by limiting open handling steps and helping maintain consistent processing conditions. They are used across different stages of cell therapy manufacturing, including cell collection, processing, expansion, formulation, and final preparation. Understanding closed systems involves examining their components, connections, automation, contamination control, and operational requirements. This article explains the basic principles of closed systems, their potential advantages, important considerations, and how they contribute to more controlled cell therapy.
Cell therapy production requires careful handling of living cells through multiple processing stages. Because these materials can be sensitive to environmental conditions, manufacturers focus on maintaining controlled processes and reducing opportunities for contamination. Closed systems are designed to support this goal by limiting direct exposure of the product and process materials to the surrounding environment. They can incorporate sterile connections, tubing, bags, containers, sensors, and automated equipment to create a more controlled workflow.
A closed system generally refers to a manufacturing setup in which the cell product and processing materials remain contained within sterile pathways rather than being repeatedly exposed to the surrounding environment. The level of closure can vary depending on the equipment, process design, and validated manufacturing procedure.
Closed processing can be used during activities such as cell washing, concentration, separation, activation, expansion, formulation, and transfer. Components are often connected through sterile techniques that allow materials to move between processing units without requiring direct exposure.
Key characteristics can include:
The specific design of a closed system depends on the type of cell therapy, manufacturing scale, facility requirements, and process validation strategy.
Closed systems can provide several operational advantages when appropriately designed and validated. Reducing open processing steps may help lower opportunities for environmental contamination and can simplify certain manufacturing workflows. They may also support automation, which can improve process consistency and reduce reliance on repetitive manual interventions.
Important considerations include:
Closed systems do not automatically eliminate every manufacturing risk. Their effectiveness depends on appropriate system design, validated procedures, equipment maintenance, environmental controls, and careful operator practices. Manufacturers therefore evaluate the complete process rather than relying on closure alone.
Overall, closed systems represent an important approach to controlling cell therapy manufacturing workflows. By limiting open handling and supporting contained processing, they can contribute to consistent and controlled production environments. Understanding how these systems work helps explain their growing role in modern cell therapy manufacturing.